Fosun Pharma (600196.SH), is a leading pharmaceutical enterprise in China. Its businesses cover pharmacy, clinical diagnostic and therapeutic products targeting the global market.
In 2007, Fosun Pharmacy won the title of one of China' s Top 100 Enterprises. Fosun Pharmacy attaches great importance to R&D and has a technical centre at China' s national level. In China, Fosun Pharmacy is the leader in several segmented markets, such as liver diseases, diabetes, gynecology and clinical diagnosis.Fosun Pharmacy is also a leading player in anti-malaria medicine in the global market and is China' s only WHO direct supplier.
Sinopharm Medicine Holding Co., Ltd, one of the major associates of the Group, recorded growth in its business and remained as the top distributor of pharmaceuticals in China.
Sinopharm Medicine Holding Co., Ltd is China' s largest drug distributor with about 10% market share. The company holds shares in two listed companies: Sino Pharm (600511.SH) and Accord Pharm (000028.SZ)
Sinopharm retained its core business of drug distribution and devoted great effort to develop a modern distribution and retail logistics system for pharmaceutical products. Sinopharm is now concentrating on establishing a strategic system with core competence. กก
Haixiang Pharmaceutical and Chemical Co. Ltd (002099. SZ) is listed on the Shenzhen Stock Exchange.
The company is China' s major producer of chemical active pharmaceutical ingredient and ranked the first in the country by production volumes in many of their major products.
